Call for companies: Merck Millipore Seeking to Meet Biotech Companies & Researchers

Nov. 19-24, 2017

* Priority for IATI members *

We are pleased to inform you that Merck Millipore Contract Development Organization (CDMO), which provides Bio-development services, plans to visit in Israel between November 19th to 24th, 2017. 

This call is for small Biotech companies, start-ups or academic research groups that would like to participate in the upcoming event or to schedule a F2F meeting with Merck representatives.

The Merck Biodevelopment Services has 3 different sites, Martillac near Bordeaux FrancecGMP manufacturing facility, Boston USA and Shanghai with the aim to support Biotech start-ups transitioning from late research to early clinical phase including GMP manufacturing Phase 1-2-3 with the possibility to go up to commercial.


General terms:

No royalties neither as upfront payment.
No IP kept and no proprietary technology used during process development.
No booking fee for slot.
Total freedom to operate.

 
The areas of activity: 

USP, DSP to drug product 
Cell line generation, Media, and feed selection, Clone selection, Cell line adaptation, Bank generation, Bank storage, Upstream definition.
Chromatography media screening, Viral inactivation/filtration step design, Sterile filtration optimization, TFF step design, Precipitation step design, Single-use implementation.

For more information, please contact Inbar Yacoby at Inbar@iati.co.il